Compare · head to head
GC Biopharma vs Innovent Biologics
Innovent Biologics ranks higher overall — 360 rank 68 vs 52.
GC Biopharma leads on Value (62 vs 40). Innovent Biologics leads on Safety (62 vs 25). The two are close on Quality, Growth and Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | South Korea | China |
| Sector | Health Care | Health Care |
| Industry | Biotechnology | Biotechnology |
| Size | Small | Large |
| ISIN | KR7006280002 | KYG4818G1010 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 52 | 68 |
| Value | 62 | 40 |
| Quality | 67 | 67 |
| Growth | 50 | 49 |
| Safety | 25 | 62 |
| Sentiment | 47 | 51 |
| Quality details | ||
| Profitability | 76 | 60 |
| Cash Truth | 58 | 74 |
GC Biopharma vs JW PharmaceuticalGC Biopharma vs Green CrossGC Biopharma vs HandokGC Biopharma vs Chong Kun DangAdd a third stock →
Full analyses: GC Biopharma · Innovent Biologics
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100